Category Health/Medical

Genentech Announces favorable results for MS drug Ocrelizumab

Phase III clinical trials has been released for its multiple scleroses drug ocrelizumab, for use in relapsing forms of the disease or in cases of primary progressive multiple sclerosis (PPMS)—and the results appear to be very promising.

Ocrelizumab is a recombinant humanized monoclonal antibody against immune B cells that express CD20 proteins at their surface. These cells are thought to be a key contributor to the myelin and neuron damage that leads to motor function impairment, irreversible neurological disability and paralysis in MS patients. “B cells can contribute to the pathophysiology of MS,” explained Dr. Hauser during his presentation, “targeting CD20-B cells may preserve B cell reconstitution and long-term immune memory.”

85% of patients with MS experience relapse, wit...

Read More

Mitochondrial DNA mutations affect Male and Female Fertility and Ageing

 Mitochondrial genome figure 1

Using Drosophila (the fruit fly) as a model organism, the research team had identified a single nucleotide mutation in the mitochondrial DNA sequence which encodes one of the core energy producing genes.

“This mutation made males sterile but remarkably the ill effects were observed only in males; females who harbour this mutation maintain their fertility. This very same mutation that causes male infertility results in them living longer than flies that don’t have this mutation. However, while remaining fertile, females that carry this mutation have shorter lives,” Ms Camus said.
Co-author Dr Ted Morrow, University of Sussex, said that this mutation is not the only one located within the mitochondria to affect longevity.

Human mitochondrial DNA.

Human mitochondrial DNA.

Dr Damian Dowling suggested the study repres...

Read More

Measurements of Heritability Calculated in 9 Autoimmune Diseases that begin in childhood

 

The research may strengthen researchers’ abilities to better predict a child’s risk for associated autoimmune diseases. Autoimmune diseases, eg type 1 diabetes, Crohn’s disease and juvenile idiopathic arthritis, collectively affect 1 in 12 persons in the Western hemisphere. They represent a significant cause of chronic disability.

“The results from this study enable us to better understand the genetic component of these diseases and how they are genetically related to each other, thereby explaining why different autoimmune disorders often run in the same family,” said Hakon Hakonarson, M.D., Ph.D.

The research encompassed 9 pediatric-onset autoimmune diseases (pAIDs): type 1 diabetes, celiac disease, juvenile idiopathic arthritis, common variable immunodeficiency, systemic lupus eryth...

Read More

Immune Gene Prevents Parkinson’s disease, Dementia

Highlights •Lack of neuronal IFN-β-IFNAR signaling causes brain Lewy body accumulation •IFN-β deficiency causes late-stage autophagy block and thereby α-synuclein aggregation •IFN-β promotes neuronal autophagy and α-synuclein clearance •Ifnb gene therapy prevents dopaminergic neuron loss in a familial PD model

Highlights •Lack of neuronal IFN-β-IFNAR signaling causes brain Lewy body accumulation •IFN-β deficiency causes late-stage autophagy block and thereby α-synuclein aggregation •IFN-β promotes neuronal autophagy and α-synuclein clearance •Ifnb gene therapy prevents dopaminergic neuron loss in a familial PD model

Non-inheritable PD may be caused by functional changes in the immune regulating gene Interferon-beta. Treatment with Interferon-beta-gene therapy successfully prevented neuronal death and disease effects in an experimental model of PD.

7-10 million people worldwide are living with PD. More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer’s disease...

Read More